Takahiro Domoto
Kanazawa, 9200934, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: July 28, 2023
Deactivation of glycogen synthase kinase-3β by heat shock‑inducible tumor small protein attenuates hyperthermia‑induced pro‑migratory activity in colorectal cancer cells.
Journal: International journal of oncology
Published: June 01, 2022
Discovery of a Novel Aminocyclopropenone Compound That Inhibits BRD4-Driven Nucleoporin NUP210 Expression and Attenuates Colorectal Cancer Growth.
Journal: Cells
Published: November 12, 2021
Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Journal: Scientific reports
Published: February 27, 2020
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
Journal: Cancer science
Published: July 05, 2019
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma.
Journal: Scientific reports
Published: February 19, 2019
Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction.
Journal: Oncotarget
Published: April 21, 2017
Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Journal: Oncotarget
Published: September 09, 2016
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy.
Journal: Cancer science
Published: April 23, 2016
Tip60 regulates MT1-MMP transcription and invasion of glioblastoma cells through NF-κB pathway.
Journal: Clinical & experimental metastasis
Published: April 24, 2015
Last Updated: 09/26/2026